Market News

North America Anti-snoring Devices and Snoring Surgery Market News

North America Anti-Snoring Devices and Snoring Surgery Market By Product Type (Oral Appliances/Mouthpieces, Nasal Devices, Position Control Devices, Chin Straps, EPAP Therapy Devices, CPAP Devices), By Type (UPPP, LAUP, Radiofrequency Ablation, Pillar Procedure, Palatal Stiffening Procedures, Injection Snoreplasty, Others), By End User (Hospitals, Community Healthcare, Sleep Clinics, Home Healthcare, Others), By Distribution Channel (Retail, Direct Sales), Country (U.S., Canada, Mexico)– Industry Trends and Forecast to 2024

The major factors driving the growth of this market are the rise in the geriatric as well as obese population, more of technological advancement, growing awareness regarding ill effects of snoring and related advantages, increase in the consumption of cigarettes and alcohol are furthermore boosting the growth of the global anti-snoring devices and snoring surgery market. On the other hand, stringent regulatory procedures and high cost of equipment may hinder the growth of the market. The anti-snoring devices and snoring surgery market in the North America region is leading in U.S.

The North America anti-snoring devices and snoring surgery market is segmented based on type into six notable segments; Uvulopalatopharyngoplasty (UPPP), Laser-Assisted Uvulopalatoplasty (LAUP), Radiofrequency Ablation (somnoplasty), Pillar Procedure, Palatal Stiffening Procedures, Injection Snoreplasty/Sclerotherapy and Others. In 2017, Uvulopalatopharyngoplasty (UPPP) segment is expected to dominate the NA anti-snoring devices and snoring surgery market with 27.1% market share and is expected to reach USD 2,215.41 million by 2024, with a CAGR of 9.3% in the forecast period 2017 to 2024. However, Radiofrequency Ablation (somnoplasty) segment is expected to grow with the highest CAGR of 11.3% in the forecast period, and is expected to reach USD 1,891.92 million in 2024 from USD 810.23 million in 2016.

Key Points: North America Anti-Snoring Devices and Snoring Surgery Market

  • In 2016, the NA anti-snoring devices and snoring surgery market is dominated by Medtronic, followed by GE Healthcare and Koninklijke Philips N.V.
  • Oral appliances/mouthpieces segment is expected to dominate the NA anti-snoring devices and snoring surgery market.
  • The anti-snoring devices and snoring surgery market in the North America region is leading in U.S., Canada, and Mexico. U.S. accounts for the highest market share in this region.

On the basis of end user, the North America anti-snoring devices and snoring surgery market is segmented into five notable segments; hospitals, home healthcare, sleep clinics, community healthcare and others. In 2017, hospitals segment is expected to dominate the North America anti-snoring devices and snoring surgery market with 57.7% market share and is expected to reach USD 4924.79 million by 2024, with a CAGR of 8.9% in the forecast period 2017 to 2024. However, home healthcare segment is expected to grow at the highest CAGR of 10.8% in the forecast period, and is expected to reach USD 2413.99 million in 2024 from USD 1074.88 million in 2016.

The major factors driving the growth of this market are the rise in the geriatric as well as obese population, more of technological advancement, growing awareness regarding ill effects of snoring and related advantages, increase in the consumption of cigarettes and alcohol are furthermore boosting the growth of the global anti-snoring devices and snoring surgery market. On the other hand, stringent regulatory procedures and high cost of equipment may hinder the growth of the market. The anti-snoring devices and snoring surgery market in the North America region is leading in U.S.

Leave a Reply